Q32 Bio, Inc. (QTTB)
7.87
+0.35
(+4.65%)
USD |
NASDAQ |
Oct 19, 15:34
Q32 Bio Cash from Operations (Annual) : -33.54M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -33.54M |
| December 31, 2024 | -67.72M |
| December 31, 2023 | -18.68M |
| December 31, 2022 | -113.66M |
| December 31, 2021 | -109.75M |
| Date | Value |
|---|---|
| December 31, 2020 | -94.33M |
| December 31, 2019 | -91.36M |
| December 31, 2018 | -42.56M |
| December 31, 2017 | 6.479M |
| December 31, 2016 | -8.484M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Intellia Therapeutics, Inc. | -394.74M |
| Beam Therapeutics, Inc. | -345.10M |
| Prime Medicine, Inc. | -162.56M |
| Prelude Therapeutics, Inc. | -56.30M |
| Twist Bioscience Corp. | -47.63M |